featured
Risk of Diabetic Retinopathy and Diabetic Macular Oedema With SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
Diabetologia 2024 Jul 01;67(7)1271-1282, A Eleftheriadou, D Riley, SS Zhao, P Austin, G Hernández, GYH Lip, TL Jackson, JPH Wilding, U AlamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.